RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
1-Year Return
12.81%
This Quarter Return
+15.35%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$561M
AUM Growth
+$216M
(+63%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
30.19%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
100
New
15
Increased
48
Reduced
17
Closed
11
Top Buys
| 1 |
Merck
MRK
|
$12.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.3M |
| 3 |
Universal Health Services
UHS
|
$10.2M |
| 4 |
Amgen
AMGN
|
$9.56M |
| 5 |
Nektar Therapeutics
NKTR
|
$8.34M |
Top Sells
| 1 |
Universal Technical Institute
UTI
|
$6.79M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$5.83M |
| 3 |
Gilead Sciences
GILD
|
$4.63M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$4.37M |
| 5 |
CELG
Celgene Corp
CELG
|
$3.57M |
Sector Composition
| 1 | Healthcare | 88.44% |
| 2 | Financials | 0.78% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
51
DELISTED
Abiomed Inc
ABMD
| $3.94M | 0.66% |
55,000
-18,000
| -25% | -$1.29M |
|
|
OCR
52
DELISTED
OMNICARE INC
OCR
| $3.85M | 0.65% |
50,000
+25,000
| +100% | +$1.93M |
|
|
KERX
53
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.78M | 0.64% |
297,000
+206,576
| +228% | +$2.63M |
|
|
THOR
54
DELISTED
THORATEC CORPORATION
THOR
| $3.64M | 0.61% |
87,000
-5,000
| -5% | -$209K |
|
55
Rigel Pharmaceuticals
RIGL
$688M
| $3.57M | 0.6% |
+100,000
| New | +$3.57M |
|
56
Centene
CNC
$14B
| $3.39M | 0.57% |
96,000
-16,000
| -14% | -$566K |
|
57
Hologic
HOLX
$14.6B
| $3.34M | 0.56% |
101,000
+7,000
| +7% | +$231K |
|
58
MacroGenics
MGNX
$116M
| $3.33M | 0.56% |
106,000
+31,000
| +41% | +$972K |
|
59
Celldex Therapeutics
CLDX
$1.49B
| $3.32M | 0.56% |
7,933
-3,734
| -32% | -$1.56M |
|
|
ELGX
60
DELISTED
Endologix Inc
ELGX
| $3.31M | 0.56% |
19,400
| – | – |
|
61
Perrigo
PRGO
$3.21B
| $3.31M | 0.56% |
+20,000
| New | +$3.31M |
|
|
STJ
62
DELISTED
St Jude Medical
STJ
| $3.19M | 0.54% |
48,800
+8,800
| +22% | +$576K |
|
|
ARIA
63
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.19M | 0.54% |
387,000
-10,000
| -3% | -$82.4K |
|
|
ANTH
64
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $3.14M | 0.53% |
87,664
+37,664
| +75% | +$1.35M |
|
65
Teva Pharmaceuticals
TEVA
$21.3B
| $3.12M | 0.53% |
+50,000
| New | +$3.12M |
|
|
TSRO
66
DELISTED
TESARO, Inc.
TSRO
| $3.04M | 0.51% |
52,999
-9,652
| -15% | -$554K |
|
67
Ligand Pharmaceuticals
LGND
$3.27B
| $3.01M | 0.51% |
62,517
| – | – |
|
68
Insulet
PODD
$24.5B
| $3M | 0.51% |
90,000
+38,000
| +73% | +$1.27M |
|
|
CPHD
69
DELISTED
Cepheid Inc
CPHD
| $2.96M | 0.5% |
52,000
| – | – |
|
70
Stryker
SYK
$151B
| $2.95M | 0.5% |
+32,000
| New | +$2.95M |
|
|
ARRY
71
DELISTED
Array Biopharma Inc
ARRY
| $2.95M | 0.5% |
400,000
-145,000
| -27% | -$1.07M |
|
72
Xencor
XNCR
$590M
| $2.91M | 0.49% |
190,000
+140,000
| +280% | +$2.14M |
|
73
Omnicell
OMCL
$1.51B
| $2.81M | 0.47% |
+80,000
| New | +$2.81M |
|
|
ACHN
74
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.76M | 0.47% |
280,000
-88,000
| -24% | -$868K |
|
75
Dynavax Technologies
DVAX
$1.19B
| $2.76M | 0.46% |
122,835
| – | – |
|